Monograph Details
|
|
Gastrointestinal Tract
> Colorectal disorders
|
|
XYRALID RC |
| Manufacturer |
|
Auriga Laboratories, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Topical anesthetic + steroid. |
| Generic Name |
|
Lidocaine HCl 3%, hydrocortisone acetate 1%; rectal crm. |
| Indications |
|
Hemorrhoids. Anal fissures. Pruritus ani. |
| Children |
|
Not recommended. |
| Adults |
|
Apply to affected area twice daily. |
| Contraindications |
|
Tuberculosis. Fungal lesions. Vaccinia. Varicella. Acute herpes simplex. |
| Precautions |
|
Hepatic dysfunction. Avoid eyes, mouth, ears, nose, mucous membranes, and abraded, fissured or irritated skin. Discontinue if irritation, sensitivity, or infection occurs. Debilitated. Elderly. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Additive effects with Class I antiarrhythmics. |
| Adverse Reactions |
|
Local irritation, burning, transient blanching, erythema; adrenal suppression. |
| How Supplied |
Cream—7g
Kit—14 x (creams [7g] + applicators + cleansing wipes) |
|
|
|
|
